Antiparkinson mao reversible inhibitor

Details Antiparkinson mao reversible inhibitor Antiparkinson mao reversible inhibitor

A - Human Necessities

61

K

A61K 31/535 (2006.01)

Patent

CA 2067170

2067170 9202224 PCTABS00010 Use of caroxazone for the manufacture of a medicament having a new therapeutic use in the treatment of Parkinson's disease and other neurodegenerative conditions related to endogenous and/or exogenous toxins, alone or in association with other antiparkinson agents.

Affiliated with

Also associated with

Rating

Antiparkinson mao reversible inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiparkinson mao reversible inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiparkinson mao reversible inhibitor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1722082